The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8.
The Board of Directors in Redsense Medical AB (publ) ("Redsense" or the "Company") announces today that the Company’s Board of Directors, with the support from the authorization from the Annual General Meeting of 2023, has resolved on a directed cash issue of a maximum of 1,404,081 shares to ShapeQ GmbH at a subscription price of SEK 7 per share (the “Directed Issue”) Through the Directed Issue, the Company will receive a maximum of approximately MSEK 9,8, before deduction of costs related to the issue.The Board of Directors has resolved that the Directed Issue of a maximum of 1,404,081